Aslı Gecgel

11PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 26, 2026
FOLFOX Plus Bevacizumab Rechallenge Versus Regorafenib as Third-Line Treatment in Metastatic Colorectal Cancer: The Role of the Oxaliplatin-Free Interval.

|Sep 01, 2026
A hidden danger in cancer patients: intestinal parasites.

|Jul 29, 2026
Clinical Outcomes of Lenvatinib-Pembrolizumab in a High-Risk, Dual ICI-Refractory Melanoma Cohort.

|Jul 28, 2026
Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study.

|Dec 30, 2025
Prognostic Value of CONUT and ALBI in Metastatic Pancreatic Cancer: A Retrospective Cohort Study.

Pınar Peker, Aslı Geçgel, Serdar Yılmaz

|Oct 29, 2025
Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Buket Şahin Çelik, Aslı Geçgel, Oğuzcan Özkan

Pageof 2

Frequent Collaborators

5 joint publications

Oğuzcan Özkan

4 joint publications

Pınar Peker

3 joint publications

Erdem Göker

2 joint publications

Alpay Duşgun